These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 28696828

  • 1. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y, Huang H, Yang H, Chen D, Wu S, Jiang Z, Wang R.
    Cell Cycle; 2017 Jul 18; 16(14):1376-1383. PubMed ID: 28696828
    [Abstract] [Full Text] [Related]

  • 2. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y, Wang Y, Fan X, Song J, Wu H, Han J, Lu L, Weng X, Nie G.
    Biochem Biophys Res Commun; 2018 Sep 10; 503(3):1214-1220. PubMed ID: 30017199
    [Abstract] [Full Text] [Related]

  • 3. The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines.
    Klenke S, Akdeli N, Stelmach P, Heukamp L, Schulte JH, Bachmann HS.
    BMC Cancer; 2019 Mar 18; 19(1):243. PubMed ID: 30885150
    [Abstract] [Full Text] [Related]

  • 4. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J, Yu Y, Li ZL, Chen MY, Deng R, Huang X, Wang GF, Zhang MX, Yang Q, Ravichandran S, Feng GK, Xu XL, Yang CL, Qiu MZ, Jiao L, Yang D, Zhu XF.
    Theranostics; 2018 Mar 18; 8(6):1494-1510. PubMed ID: 29556337
    [Abstract] [Full Text] [Related]

  • 5. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
    Li N, Feng L, Han HQ, Yuan J, Qi XK, Lian YF, Kuang BH, Zhang YC, Deng CC, Zhang HJ, Yao YY, Xu M, He GP, Zhao BC, Gao L, Feng QS, Chen LZ, Yang L, Yang D, Zeng YX.
    Cancer Lett; 2016 Oct 10; 381(1):14-22. PubMed ID: 27424523
    [Abstract] [Full Text] [Related]

  • 6. Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.
    Luo F, Lu FT, Qiu MZ, Zhou T, Ma WJ, Luo M, Zeng KM, Luo QY, Pan WT, Zhang L, Xia ZF, Zhang ZH, Cao JX, Zhao HY, Zhang L, Yang DJ.
    Cell Death Dis; 2021 Aug 05; 12(8):772. PubMed ID: 34354046
    [Abstract] [Full Text] [Related]

  • 7. TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis.
    Ashimori N, Zeitlin BD, Zhang Z, Warner K, Turkienicz IM, Spalding AC, Teknos TN, Wang S, Nör JE.
    Mol Cancer Ther; 2009 Apr 05; 8(4):893-903. PubMed ID: 19372562
    [Abstract] [Full Text] [Related]

  • 8. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
    Mohammad RM, Goustin AS, Aboukameel A, Chen B, Banerjee S, Wang G, Nikolovska-Coleska Z, Wang S, Al-Katib A.
    Clin Cancer Res; 2007 Apr 01; 13(7):2226-35. PubMed ID: 17404107
    [Abstract] [Full Text] [Related]

  • 9. Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.
    Cao LH, Li HT, Lin WQ, Tan HY, Xie L, Zhong ZJ, Zhou JH.
    Sci Rep; 2016 Jan 05; 6():18706. PubMed ID: 26729257
    [Abstract] [Full Text] [Related]

  • 10. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y, Zhang J, Tian Y, Xue C, Hu Z, Zhang L.
    Drug Des Devel Ther; 2015 Jan 05; 9():4897-907. PubMed ID: 26345996
    [Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of the dual mTORC1/2 inhibitor sapanisertib in combination with cisplatin in nasopharyngeal carcinoma.
    Zhang J, Jiang Y, Yu Y, Li J.
    Eur J Pharmacol; 2022 Jan 15; 915():174688. PubMed ID: 34883074
    [Abstract] [Full Text] [Related]

  • 12. Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
    Low SY, Tan BS, Choo HL, Tiong KH, Khoo AS, Leong CO.
    Cancer Lett; 2012 Jan 28; 314(2):166-75. PubMed ID: 22033244
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.
    Zhang JX, Qian D, Wang FW, Liao DZ, Wei JH, Tong ZT, Fu J, Huang XX, Liao YJ, Deng HX, Zeng YX, Xie D, Mai SJ.
    Cancer Lett; 2013 Feb 01; 329(1):91-8. PubMed ID: 23142283
    [Abstract] [Full Text] [Related]

  • 14. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
    Liu SL, Lin HX, Lin CY, Sun XQ, Ye LP, Qiu F, Wen W, Hua X, Wu XQ, Li J, Song LB, Guo L.
    Cancer Lett; 2017 Aug 28; 402():117-130. PubMed ID: 28583847
    [Abstract] [Full Text] [Related]

  • 15. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target.
    Xie P, Yang JP, Cao Y, Peng LX, Zheng LS, Sun R, Meng DF, Wang MY, Mei Y, Qiang YY, Cao L, Xiang YQ, Luo DH, Yun JP, Huang BJ, Jia LJ, Qian CN.
    Cell Death Dis; 2017 Jun 01; 8(6):e2834. PubMed ID: 28569775
    [Abstract] [Full Text] [Related]

  • 16. Chemosensitizing Effect of Astragalus Polysaccharides on Nasopharyngeal Carcinoma Cells by Inducing Apoptosis and Modulating Expression of Bax/Bcl-2 Ratio and Caspases.
    Zhou Z, Meng M, Ni H.
    Med Sci Monit; 2017 Jan 26; 23():462-469. PubMed ID: 28124680
    [Abstract] [Full Text] [Related]

  • 17. ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts.
    Hu ZY, Zhu XF, Zhong ZD, Sun J, Wang J, Yang D, Zeng YX.
    Int J Cancer; 2008 Nov 15; 123(10):2418-29. PubMed ID: 18712728
    [Abstract] [Full Text] [Related]

  • 18. Tetrandrine Induces Apoptosis in Human Nasopharyngeal Carcinoma NPC-TW 039 Cells by Endoplasmic Reticulum Stress and Ca2+/Calpain Pathways.
    Liu KC, Lin YJ, Hsiao YT, Lin ML, Yang JL, Huang YP, Chu YL, Chung JG.
    Anticancer Res; 2017 Nov 15; 37(11):6107-6118. PubMed ID: 29061791
    [Abstract] [Full Text] [Related]

  • 19. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
    Zhang M, Zhou X, Zhou K.
    Int J Mol Med; 2013 Mar 15; 31(3):621-7. PubMed ID: 23314035
    [Abstract] [Full Text] [Related]

  • 20. LncRNA NEAT1/miR-129/Bcl-2 signaling axis contributes to HDAC inhibitor tolerance in nasopharyngeal cancer.
    Xue F, Cheng Y, Xu L, Tian C, Jiao H, Wang R, Gao X.
    Aging (Albany NY); 2020 Jul 21; 12(14):14174-14188. PubMed ID: 32692721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.